Eco R1 Capital, LLC Gracell Biotechnologies Inc. Transaction History

Eco R1 Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.8 - $2.5 $4.58 Million - $6.36 Million	-2,544,254 Reduced 76.1%	798,948 $1.49 Million
Q4 2022 Feb 14, 2023	BUY	$2.08 - $3.96 $2.96 Million - $5.63 Million	1,421,892 Added 74.01%	3,343,202 $7.69 Million
Q2 2022 Aug 15, 2022	BUY	$1.95 - $5.5 $705,120 - $1.99 Million	361,600 Added 23.18%	1,921,310 $10.6 Million
Q1 2022 May 16, 2022	BUY	$1.83 - $5.52 $2.85 Million - $8.61 Million	1,559,710 New	1,559,710 $3.63 Million

75.1K

Ticker GRCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,674,096
Description
Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the tre...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.